Published by ChinaMNC · Wuding

Yunnan's 15th Five-Year Plan for Traditional Chinese Medicine Materials: What Foreign Founders Need to Know

Yunnan Province has released a plan to reshape its traditional Chinese medicine (TCM) material industry by 2030. Foreign founders in pharmaceuticals, health products, and agribusiness should understand the key targets and opportunities, from GAP bases to AI-driven systems.

Yunnan's New Plan for TCM Materials

Yunnan Province has published its 15th Five-Year Plan for the development of the traditional Chinese medicine (TCM) materials industry. The plan sets targets for 2030 and outlines eight key tasks. For foreign founders considering China-based operations in herbal medicine, health products, or agribusiness, the plan signals where provincial support is heading. Below is a factual summary based on the official government release.

Core targets: fewer acres, more value

By 2030, Yunnan expects to reduce the area used for TCM material cultivation by 1.608 million mu (about 107,200 hectares) while increasing the industry's comprehensive output value by 50 billion yuan. The strategy is to trade area for quality, processing depth, branding, and efficiency.

1. Optimizing variety layout: what to grow

Building on the 156 varieties listed in the 2024 Yunnan Dao-di Medicinal Materials Catalog, the plan prioritizes three groups:

• Dao-di advantage varieties: the “Top Ten Yunnan Medicines,” led by Panax notoginseng (sanqi), plus Paris polyphylla (chonglou), Erigeron breviscapus (dengzhanhua), Dendrobium officinale (tiepi shihu), Amomum villosum (sharen), Gastrodia elata (tianma), Poria cocos (yun fuling), Angelica sinensis (yun danggui), Aucklandia lappa (yun muxiang), and Gentiana rigescens (dianlongdan).
• Health-resource varieties: the “Top Ten Health Resources,” including Polygonatum kingianum (dian huangjing), safflower (honghua), Bletilla striata (baiji), Dendrobium candidum (zipi shihu), Phyllanthus emblica (yuganzi), Coix seed (yiyiren), Terminalia chebula (hezi), Amomum tsaoko (caoguo), ginger, and star anise.
• Potential varieties: the “Six Southern Medicines,” such as Amomum villosum (sharen), Dragon’s blood (longxuejie), Cibotium barometz (gouji), agarwood (chenxiang), Orthosiphon aristatus (shencha), and Dai bai jie.

2. Accelerating standardized production: how to grow

The plan aims to establish 200 Good Agricultural Practice (GAP) bases for TCM materials. A priority is full GAP coverage for sanqi in Wenshan. The province will also advance GAP bases for under-forest varieties such as Poria (fuling), Amomum (sharen), Amomum tsaoko (caoguo), and Phellodendron (huangbo), and seek to create a number of national-level high-standard raw material production bases.

3. Under-forest cultivation: where to grow

Focusing on dao-di herbs such as sanqi, tianma, fuling, sharen, huangjing, and huangbo, the plan promotes under-forest cultivation and ecological planting. The target is to expand ecological and under-forest bases to more than 6 million mu.

4. Primary processing at origin: handling after harvest

The plan supports setting up primary processing lines in dao-di production areas and high-standard raw material bases. It aims to link GAP-base materials with fresh-cut processing and upgrade products from raw materials to semi-industrialized input materials.

5. High-value products: increasing returns

Enterprises are encouraged to build modern deep-processing lines and develop high-value-added products, forming a series of Yunnan medicine health products. The plan also promotes R&D and industrialization of health products in areas such as daily chemicals and cosmetics, and functional wellness.

6. Preventing blind expansion: stabilizing the market

For bulk and scarce varieties vulnerable to market swings—such as sanqi, danggui, and chonglou—the plan calls for market-based adjustment to smooth price fluctuations. An information monitoring and early-warning system will be built to guard against risks like “blind expansion” and “low prices hurting farmers.”

7. Food-medicine homology development: new uses

The plan includes developing standards for food-medicine homology raw materials and production processes. It aims to complete cross-border registration for 5–10 new products and plans to organize a “Yunnan Medicine Food-Medicine Homology Culture Festival.”

8. “Yunnan Medicine Brain”: smart industry

An AI innovation application project called “Yunnan Medicine Brain” will be implemented. It seeks to build an intelligent application system covering the entire life cycle of TCM materials and to develop multi-level, multi-scenario smart solutions in key areas.

What this means for foreign founders

For foreign entrepreneurs, the plan highlights several entry points. If you are considering a company in China focused on herbal cultivation, processing, or health products, Yunnan’s focus on GAP bases, under-forest planting, and deep processing may align with your business model. The province’s push for standards and cross-border registration could also ease market access for compliant products. However, the plan does not provide specific incentives or guarantees for foreign investors; those would need to be confirmed with local authorities.

When setting up operations, foreign founders should note that TCM materials are subject to Chinese regulations on agriculture, pharmaceuticals, and food safety. The plan’s emphasis on GAP and standards suggests that compliance will be increasingly important. Engaging local partners and understanding provincial priorities can help navigate the landscape.

Call to action: Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.